National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 89019 [2024-26110]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices
Contact Person: Erica L. Brown, Ph.D.,
Director, Division of Extramural Activities,
National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 2AN24C, Bethesda,
MD 20892, 301–594–4499, erica.brown@
nih.gov.
Members of the public are welcome to
provide written comments by emailing
NIGMS_DEA_Mailbox@nigms.nih.gov at least
3 days in advance of the meeting. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: November 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–26074 Filed 11–8–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Data Use Certification for the
NIH Brain Development Cohorts
(NBDC), (National Institute on Drug
Abuse)
ACTION:
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2024–26110 Filed 11–8–24; 8:45 am]
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Acquired Immunodeficiency
Syndrome Research Study Section Acquired
Immunodeficiency Syndrome Research
Study Section.
Date: December 6, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3D32,
Rockville, MD 20892 (Video Assisted
Meeting).
Jkt 265001
National Institutes of Health,
HHS.
National Institutes of Health
16:35 Nov 08, 2024
Dated: November 5, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3D32, Rockville, MD
20892, (240) 669–5035, robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Notice.
The purpose of this revision
is to clarify inclusion of the HBCD
Study, to update data use terms and
conditions, and to request a progress
report statement at the time of renewal.
Burden levels remain unchanged.
In compliance with the requirement
of the Paperwork Reduction Act of 1995
to provide opportunity for public
comment on proposed data collection
projects, the National Institute on Drug
Abuse (NIDA) will publish periodic
summaries of proposed projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
SUMMARY:
Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
DATES:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Elizabeth A. Hoffman,
Associate Director, Division of
Extramural Research, National Institute
on Drug Abuse, 3WFN Room 09C75
MSC 6021, Gaithersburg, MD 20877, or
call non-toll-free number (301) 594–
2265 or Email your request, including
your address to: elizabeth.hoffman@
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
89019
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title: Data Use
Certification for the NIH BRAIN
Development Cohorts (NBDC), (NIDA)
0925–0780, exp., date 10/31/2026
REVISION, National Institute on Drug
Abuse (NIDA), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The purpose of this proposal
is to inform data requestors about terms
and conditions for using data generated
by the Adolescent Brain Cognitive
Development (SM) (ABCD) Study and the
Healthy Brain and Child Development
(HBCD) Study, collectively known as
the NIH Brain Development Cohorts
(NBDC), and to obtain signed
agreements from requestors and their
institutional officials attesting to their
commitment to abide by the data use
terms and conditions. These include
using data for research purposes;
adhering to human subjects research
requirements; not distributing the data
to non-authorized users; minimizing
risk of participant identifiability; using
data ethically and responsibly; and
keeping the data secure. Recipients
must include a brief description of their
research project and submit their signed
data use agreements to the data
repository to gain access to NBDC Study
data. Recipients who plan to conduct
research studies specifically on
American Indian/Alaska Native (AI/AN)
populations must submit an additional
signed data use certification.
OMB approval is requested for 3
years. There are no costs to respondents
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 89, Number 218 (Tuesday, November 12, 2024)]
[Notices]
[Page 89019]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26110]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group; Acquired Immunodeficiency Syndrome Research
Study Section Acquired Immunodeficiency Syndrome Research Study
Section.
Date: December 6, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3D32,
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Robert C. Unfer, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3D32,
Rockville, MD 20892, (240) 669-5035, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 5, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-26110 Filed 11-8-24; 8:45 am]
BILLING CODE 4140-01-P
